Nasal spray tested to stop Diabetics' silent danger
NCT ID NCT03608163
Summary
This study aimed to find a new way to prevent a dangerous condition where people with diabetes lose their ability to feel warning signs of low blood sugar. Researchers tested whether a nasal spray medication (naloxone) could help healthy volunteers maintain their body's natural alarm system during repeated low blood sugar episodes. The trial was stopped early and only included four healthy participants, not people with diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Conditions
Explore the condition pages connected to this study.